Hartadinata Abadi Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Hartadinata Abadi Tbk. trades at Rp1,850 (market cap 8.45T, 1.38M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp250 (market cap 167.37B, 23.1K 24h volume). The key difference: Hartadinata Abadi Tbk. is far larger — about 50.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Hartadinata Abadi Tbk. is more actively traded (1.38M versus 23.1K). Which is the better fit depends on your goals.
| HRTA | OBAT | |
|---|---|---|
Market Cap | 8.45T | 167.37B |
Volume | 1.38M | 23.1K |
Lot | 13.77K | 231 |
Turnover | 2.55B | 5.7M |
Average Price | 1,849.82 | 246.93 |
Value | 2.55B | 5.7M |
Indicative Equilibrium Price | 1,835 | 246 |
Indicative Equilibrium Volume | 13.4K | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Hartadinata Abadi Tbk (“the Company”) was established based on Notarial Deed No. 11 datedMarch 29, 2004 of Mayasari Soegiharto, S.H.
Read more on HRTA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →